Estimating the hCGβcf in urine during pregnancy.

Clin Biochem

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address:

Published: February 2016

Objective: Elevated urine concentrations of hCG beta core fragment (hCGβcf) are known to cause false negative qualitative point-of-care hCG test results, but limited information is available regarding urine hCGβcf. In this study, we evaluate the relationship between serum and urine hCG concentrations and the frequency of elevated urine hCGβcf concentrations.

Design And Methods: Paired serum and urine specimens were obtained from 60 women at various stages of pregnancy and hCG was measured using the Abbott Architect and Roche Cobas e602 assays. Urine specimens with the greatest difference in urine hCG concentrations between these two instruments were tested using a qualitative point-of-care device and hCGβcf was quantified using LC-MS/MS.

Results: Urine hCG concentrations were lower than serum and the magnitude of the difference depended on whether the hCG assay detected hCGβcf. Elevated hCGβcf concentrations (>280,000pmol/L) were observed in 12% of specimens from an unselected patient population. There was a significant correlation (r=0.97; p<0.0001) between the difference (Roche hCG-Abbott hCG) and the hCGβcf concentration as measured by LC-MS/MS (Roche-Abbott difference IU/L=(hCGβcf (pmol/L)∗0.131+656)).

Conclusions: A correlation exists between serum and urine hCG concentrations but this correlation is variable. hCGβcf concentrations can be estimated using two automated assay reagent platforms that differ in their recognition of hCGβcf.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2015.10.020DOI Listing

Publication Analysis

Top Keywords

urine hcg
12
hcg concentrations
12
urine
9
elevated urine
8
qualitative point-of-care
8
urine hcgβcf
8
serum urine
8
urine specimens
8
hcg
7
hcgβcf
6

Similar Publications

Predictive value of placental growth factor level for adverse pregnancy outcome in twin pregnancies at advanced maternal age.

Am J Transl Res

November 2024

Department of Gynaecology and Obstetrics, General Global China Railway Xi'an Hospital No. 319, East Section of South Second Ring Road, Beilin District, Xi'an 710000, Shaanxi, China.

Objective: To investigate the predictive value of placental growth factor (PlGF) for adverse pregnancy outcome in twin pregnancies at advanced maternal age.

Methods: A retrospective analysis was conducted on 387 women with twin pregnancies who delivered at Northwest Women's and Children's Hospital between March 2020 and March 2024. The women were divided into a favorable outcome group (n = 249) and an adverse outcome group (n = 138) based on their pregnancy outcome.

View Article and Find Full Text PDF

The detection of ectopic pregnancy (EP) by point-of-care ultrasound has become an integral competency of emergency medicine practice. Clinical algorithms usually include a female of childbearing age, positive urine or serum human chorionic gonadotropin (hCG) test, and an ultrasound evaluation to assess the presence or absence of intrauterine pregnancy. This case report illustrates incidental findings observed during focused assessment with sonography in trauma (FAST examination), which initially suggested an intra-ovarian EP.

View Article and Find Full Text PDF
Article Synopsis
  • Ovarian hyperstimulation syndrome (OHSS) is a common issue in patients undergoing IVF, and while current treatments are limited, acupuncture shows promise as a safe alternative, though more research is needed.
  • This study conducts a randomized controlled trial with 384 participants divided into three groups (acupuncture, sham acupuncture, and control) to assess the effectiveness of acupuncture in managing OHSS symptoms over 20 days.
  • Findings will be shared at scientific conferences and in peer-reviewed journals, having received ethical approval from the Sixth Affiliated Hospital of Sun Yat-sen University.
View Article and Find Full Text PDF

Objective: We report the first documented case of concurrent ectopic complete hydatidiform mole (CHM) and high-grade serous carcinoma (HGSC) of the fallopian tube, associated with unique histologic features and mutations in the HGSC.

Case Report: The patient presented with pelvic pain and vaginal bleeding. Laboratory examination revealed a positive urine pregnancy test and high serum beta-human chorionic gonadotropin (β-hCG).

View Article and Find Full Text PDF

Gestational trophoblastic disease is a group of pregnancy-related trophoblastic tumours. Gestational trophoblastic neoplasia refers to its invasive and malignant forms: invasive mole, choriocarcinoma, placental site trophoblastic tumour and epithelioid trophoblastic tumour. Patients exhibit elevated beta human chorionic gonadotropin (β hCG) levels, sometimes exceeding 100 000 mIU/mL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!